Main content
Listen now

'Not too late to review cost' of breast cancer drug Kadcyla

The NHS has rejected a drug that can extend lives of women with breast cancer because it is 鈥榯oo expensive鈥�. Jennifer Cozzone head of Health Economics and Pricing at Roche and Mia Rosenblatt from Breast Cancer Campaign discuss.

5 minutes

This clip is from

Today

Show available episodes

Featured in...

  • Health clips

    Listen to a selection of clips from recent and upcoming programmes.

More clips from Today

See all clips from Today (5551)